| ID | 1220 |
| Name of the vaccine | ACAM2017 |
| Microbe | Bacteria |
| Disease name | E.coli Infections |
| Name of bacteria | Escherichia coli |
| Type of vaccine | Live attenuated |
| Nucleic acid content | Circular duplex DNA |
| Age | 18 to 49 years |
| Description of the vaccine | CFA/I expressing ETEC vaccine. |
| Name of the manufacturer | NA |
| Name of the manufacturing country | NA |
| Year of manufacture | NA |
| Clinical Phase status | Clinical - Phase 1 |
| Bacterial strain | Gram-negative, rod-shaped bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Two doses. |
| Mechanism of action | ASC, ALS, serology, serum IgA and WGLF. |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | Non-serious adverse events. |
| Post vaccination | NA |
| Dose type | Combination (2 doses) |
| Interspecies transfer | NA |
| PubMed identifier | 17566016 |
| Clinical trial number | NA |
| Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=117&keywords= |
| Other name | NA |
| Additional Links | NA
|